Linkedin Twitter

H2020-IMI2-2020-20-03: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)

Deadline: 2020-11-19 Status: Closed
Description
The objectives of this call topic are to develop and implement innovative, state of the art adaptive clinical trial designs for the field of TB regimen development able to define the therapeutic dose for existing experimental New Chemical Entities (NCE’s) within treatment combinations. The funded action will develop innovative trial designs able to define optimal treatment duration against endpoints. The funded action should also prospectively validate biomarkers against a relapse endpoint.  Type of action: Research and Innovation Action.

THIS GRANT IS CURRENTLY CLOSED. SEARCH OTHER FUNDING OPPORTUNITIES OR REGISTER TO ACCESS ALL THE INFORMATION AND R&D PROJECTS OPPORTUNITIES IN YOUR AREAS OF INTEREST